HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

NIR photoresponsive drug delivery and synergistic chemo-photothermal therapy by monodispersed-MoS2-nanosheets wrapped periodic mesoporous organosilicas.

Abstract
Two-dimensional (2D) MoS2 nanosheets have attracted increasing attention in recent years owing to their various fascinating properties, particularly excellent near-infrared (NIR) photothermal feature. In this study, we synthesized a novel NIR-light-triggered drug-delivery system by wrapping MoS2 nanosheets around doxorubicin (Dox)-loaded periodic mesoporous organosilicas (PMOs) and then decorating with polyethylene glycol (PEG) to form a PMO-Dox@MoS2-PEG nanoplatform for the first time. The obtained PMO-Dox@MoS2-PEG nanoplatforms had a uniform diameter (326 nm), high Dox loading capacity (160 μg mg-1 PMOs), excellent photothermal transformation ability, and good dispersibility in physiological conditions. Note that the Dox was almost completely blocked in the PMO-Dox@MoS2-PEG nanoplatforms, and the photothermal effect of the MoS2 nanosheets could efficiently trigger the release of Dox under an 808 nm laser irradiation. Simultaneously, the PMO-Dox@MoS2-PEG nanoplatforms realized a combined chemotherapy and photothermal therapy for liver cancer cells and breast cancer cells upon NIR laser irradiation. Compared with the single photothermal therapy or chemotherapy, the combined treatment had an improved synergistic therapeutic efficacy. We believe the NIR-light-triggered drug-delivery system with synergistic chemo-photothermal therapeutic property provides a promising strategy for cancer treatment.
AuthorsTianpeng Shao , Jun Wen , Qi Zhang , Yingwen Zhou , Li Liu , Lihui Yuwen , Ying Tian , Yunlei Zhang , Wei Tian , Yunyan Su , Zhaogang Teng , Guangming Lu , Jian Xu
JournalJournal of materials chemistry. B (J Mater Chem B) Vol. 4 Issue 47 Pg. 7708-7717 (Dec 21 2016) ISSN: 2050-7518 [Electronic] England
PMID32263828 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: